24 Jul, EOD - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, EOD - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 39923.6 (-1.08)

S&P 5437.74 (-2.12)

Login/Signup

Krsnaa Diagnostics Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543328 | NSE Symbol : KRSNAA | ISIN : INE08LI01020 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose
10-May-2024 18-May-2024 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31 2024 and Recommendation of Final Dividend If Any for year ended March 31 2024. Outcome of Board Meeting held on May 18, 2024, Considering and approving the Audited Standalone and Consolidated Financial Results of the Company for Quarter and Year ended March 31, 2024 and other matters. (As Per BSE Announcement Dated on: 18/05/2024)
01-Feb-2024 12-Feb-2024 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday February 12 2024 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2023. Details regarding Grant of ESOPs. Intimation of Proposed formation of a Wholly owned Subsidiary Company. (As Per BSE Announcement Dated on 13.02.2024) Outcome of Board Meeting held on February 12, 2024, Considering and approving the Unaudited Standalone and Consolidated Financial Results of the Company for Quarter and Nine Months ended December 31, 2023 and other matters. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Appointment of Chief Executive Officer of the Company. (As per BSE Announcement Dated on 12/02/2024)
27-Oct-2023 03-Nov-2023 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday November 03 2023 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30 2023. Outcome of Board Meeting held on November 03, 2023 inter-alia approved the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2023. Unaudited Financial Results for quarter and half year ended September 30, 2023. (As Per BSE Announcement dated on 03.11.2023)
05-Aug-2023 12-Aug-2023 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday August 12 2023 to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2023. Outcome of Board Meeting (As per BSE Announcement Dated on 12/08/2023)
17-May-2023 27-May-2023 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and other applicable provisions rules and regulations if any this is to inform you that a meeting of Board of Directors (Board) of the Company is scheduled to be held on Saturday 27th May 2023 inter-alia to consider and approve: 1. Financial Results: a. Audited (Standalone and Consolidated) Financial Results for the quarter ended 31st March 2023 and to take on record the Auditors Report thereon; and b. Audited (Standalone and Consolidated) Financial Results of the Company for the financial year ended 31st March 2023 and to take on record the Auditors Report thereon. 2. Proposal for recommendation of Final Dividend for the Financial Year 2022-23. It is requested to take the same on your records Board has recommended a Dividend of Rs. 2.75/- per Equity Share, subject to approval of Shareholders at the Annual General Meeting of the company. (As per BSE Announcement Dated on 29/05/2023)
25-Mar-2023 25-Mar-2023 This is to inform you that the Board of Directors of the Company at its meeting held today, which commenced at 02:30 p.m. and concluded at 06:35 p.m., inter-alia, approved the formation of Operations Committee (Non Statutory Committee).
03-Feb-2023 13-Feb-2023 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Unaudited (Standalone and Consolidated) Financial Results ('UFR') for the quarter and nine months ended on 31st December 2022 Please find enclosed herewith Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and nine-months ended on 3i5t December, 2022 along with Limited Review report thereon. Outcome of Board Meeting held on 13.02.2023 which commenced at 02:00 p.m. and concluded at 04:30 p.m. (As Per BSE Announcement Dated on 13/02/2023)
01-Nov-2022 09-Nov-2022 Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (LODR) Regulations 2015 and all other applicable provisions in this behalf we wish to inform you that the Meeting of the Board of Directors of Krsnaa Diagnostics Limited ('the Company') is scheduled to be held on Wednesday 09th November 2022 inter alia to consider and approve Unaudited (Standalone and Consolidated) Financial Results ('UFR') for the quarter and half year ended on 30th September 2022 and to take on record the Limited Review Report thereon. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and the underlying Code of the Company the Trading Window for dealing in securities of the Company is already closed with effect from 01st October 2022. Please find enclosed herewith Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended on 30th September, 2022 along with Limited Review report thereon. This is to inform you that the Board of Directors of the Company at its meeting held today, which commenced at 01:45 p.m. and concluded at 04:57 p.m., inter-alia, unanimously approved/ consented/ took on record the following: Unaudited Results (As Per BSE Announcement Dated on 09/11/2022)
28-Jul-2022 04-Aug-2022 Quarterly Results Please find enclosed herewith Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended on 30th June, 2022 along with Limited Review report thereon. Outcome of Board Meeting (As Per BSE Announcement Dated 04.08.2022)
21-Jul-2022 21-Jul-2022 Reconstitution of Committees of the Board.
23-May-2022 28-May-2022 Final Dividend & Audited Results Board of Directors at its meeting held on 28-May-2022, Declared Dividend of Rs. 2.50 per equity share This is to inform you that the Board of Directors of the Company at its meeting held today, which commenced at 3:00 p.m. and concluded at 7:30 p.m., inter-alia, unanimously approved/consented/ took on record the following: 1. Financial Results: Audited (Standalone and Consolidated) Financial Results of the Company for the quarter and year ended 31st March, 2022. Audited (Standalone and Consolidated) Financial Results of the Company for the year ended 31st March, 2022. It is requested to take this intimation on your records. Outcome of Board Meeting held on 28-May-2022 to consider financial statements for the period ended March 2022, Dividend and change in Board of Directors. Board of Directors at its meeting held on 28-May-2022, Declared Dividend of Rs. 2.50 per equity share Change in Board of Directors: 1. Appointment of Director Appointment of Mr. Adesh Kumar Gupta (DIN: 00020403) as Independent Director, on the Board of the Company, for a term of 5 years effective from 28th May, 2022, subject to Member''s and other applicable approval(s), Further details pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, are enclosed as Annexure A. 2. Mr. Prakash Iyer (DIN: 00529591), has tendered his resignation from the post of Independent Director of the Company w.e.f. close of business hours on 28th May, 2022. The same has been taken on record by the Board of Directors in the Meeting held today. Further details pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, are enclosed as Annexure B. (As Per BSE Announcement Dated on 28.05.2022) Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith clippings of newspaper publication of the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2022, published in Financial Express (All Editions) and Loksatta (Pune Edition), both dated on 30th May, 2022. (As Per BSE Announcement Dated on 30/05/2022)
24-Jan-2022 31-Jan-2022 Quarterly Results Please find enclosed herewith Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and nine months ended 3l51 December, 2021 along with Limited Review report thereon. Outcome of Board Meeting (As per BSE Announcement Dated on 31/01/2022)
30-Sep-2021 11-Oct-2021 Quarterly Results Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended on 30th September, 2021 Outcome of the Board Meeting held on 11th October, 2021. The resignation of CS Manisha Chitgopekar from the post of Company Secretary and Compliance Officer of the Company effective from closing of business hours on Monday, 11th October, 2021 (As Per BSE Announcement dated on 11.10.2021)
1